Prospective evaluation of the factors predicting the prognosis of advanced hepatocellular carcinoma (HCC) patients treated with sorafenib.

被引：1
作者：
Adachi, Takuya
Nouso, Kazuhiro
Miyahara, Koji
Dohi, Chihiro
Wada, Nozomu
Takeuchi, Yasuto
Kuwaki, Kenji
Onishi, Hideki
Ikeda, Fusao
Nakamura, Shinichiro
Shiraha, Hidenori
Takaguchi, Koichi
Uematsu, Shuji
Iwadou, Shouta
Takuma, Yoshitaka
Hagihara, Hiroaki
Takabatake, Hiroyuki
Takaki, Akinobu
Okada, Hiroyuki
机构：
[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama, Japan
[2] Okayama Univ, Dept Gastroenterol & Hepatol, Okayama, Japan
[3] Hiroshima City Hiroshima Citizens Hosp, Hiroshima, Japan
[4] Kagawa Prefectural Cent Hosp, Takamatsu, Kagawa, Japan
[5] Sumitomo Besshi Hosp, Nihama City, Japan
[6] Kurashiki Cent Hosp, Kurashiki, Okayama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15674
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15674
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Efficacy and cost-effectiveness of antiviral therapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma treated with sorafenib.
    Li, Qiu
    Zhang, Pengfei
    Yang, Yu
    Wen, Feng
    Wheeler, Jack
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [42] Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Reis, Daniela
    Moura, Miguel
    Freitas, Luis Carlos
    Carvalhana, Sofia
    Nogueira, Paulo Jorge
    Gaio, Raquel
    Marinho, Rui Tato
    Cortez-Pinto, Helena
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E114 - E120
  • [43] Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib
    Reis, Daniela
    Moura, Miguel
    Freitas, Luis Carlos
    Carvalhana, Sofia
    Nogueira, Paulo Jorge
    Gaio, Raquel
    Marinho, Rui Tato
    Cortez-Pinto, Helena
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E114 - E120
  • [44] Japan multicenter prospective study: FDG PET/CT in the assessment of advanced renal cell carcinoma treated with sorafenib.
    Nakaigawa, Noboru
    Tateishi, Ukihide
    Kato, Takuma
    Kaneta, Tomohiro
    Kondo, Keiichi
    Sugimoto, Mikio
    Yao, Masahiro
    Inoue, Tomio
    Kakehi, Yoshiyuki
    Kubota, Yoshinobu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [45] Early increase in α-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib
    Nakazawa, Takahide
    Hidaka, Hisashi
    Takada, Juichi
    Okuwaki, Yusuke
    Tanaka, Yoshiaki
    Watanabe, Masaaki
    Shibuya, Akitaka
    Minamino, Tsutomu
    Kokubu, Shigehiro
    Koizumi, Wasaburo
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2013, 25 (06) : 683 - 689
  • [46] PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH LENVATINIB
    Sacco, R.
    Ciruolo, M.
    Paolillo, R.
    Ramai, D.
    Tortora, R.
    Di Costanzo, G. G.
    Burlone, M. E.
    Pirisi, M.
    Federico, P.
    Daniele, B.
    Silletta, M.
    Gallo, P.
    Cocuzza, C.
    Russello, M.
    Cabibbo, G.
    Cesario, S.
    Masi, G.
    Marzi, L.
    Mega, A.
    Granito, A.
    Pieri, G.
    Giannini, E.
    Gadaleta-Caldarola, G.
    Dadduzio, V
    Giordano, G.
    Giacomelli, L.
    Papa, S.
    Renzulli, M.
    Maida, M.
    Ghidini, M.
    Facciorusso, A.
    [J]. DIGESTIVE AND LIVER DISEASE, 2023, 55 : S119 - S120
  • [47] Ang-2 polymorphisms in relation to outcome in advanced HCC patients receiving sorafenib.
    Marisi, Giorgia
    Scartozzi, Mario
    Faloppi, Luca
    Foschi, Giuseppe Francesco
    Lauletta, Gianfranco
    Valgiusti, Martina
    Aprile, Giuseppe
    Fornaro, Lorenzo
    Iavarone, Massimo
    Ercolani, Giorgio
    Frassineti, Giovanni Luca
    Amadori, Dino
    Gardini, Andrea Casadei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [48] PROSPECTIVE EVALUATION OF SORAFENIB (SO) IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): DOES CHILD SCORE B INFLUENCE SAFETY?
    Romano, O.
    Cattan, S.
    Dharancy, S.
    Canva, V.
    Castel, H.
    Boleslawski, E.
    Truant, S.
    Hebbar, M.
    Pruvot, F.
    Mathurin, P.
    [J]. JOURNAL OF HEPATOLOGY, 2009, 50 : S28 - S28
  • [49] TOLLERANCE AND EFFICACY OF SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: A PROSPECTIVE STUDY
    Gaia, Silvia
    Brunocilla, Paola Rita
    Carucci, Patrizia
    Rolle, Emanuela
    Castiglione, Anna
    Rizzetto, Mario
    Brunello, Franco
    [J]. HEPATOLOGY, 2011, 54 : 1418A - 1418A
  • [50] Concomitant use of antiacids in patients with advanced hepatocellular carcinoma (HCC) receiving sorafenib therapy
    Razak, Razwan Abd
    Kunene, Victoria
    Ma, Yuk Ting
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345